Literature DB >> 35348966

LncRNA TUG1 compromised neuronal mitophagy in cerebral ischemia/reperfusion injury by targeting sirtuin 1.

Long-Xing Xue1, Song-Feng Chen2, Shi-Xing Xue3, Pei-Dong Liu4,5, Hong-Bo Liu6.   

Abstract

BACKGROUND: Mitophagy protects against cerebral ischemia/reperfusion (CI/R)-induced neuronal apoptosis via mitochondrial clearance. Although taurine-upregulated gene 1 (lncRNA TUG1) has been proposed to be involved in the neuronal apoptosis evoked by CI/R, its specific role in mitophagy during the progression of CI/R injury remains unknown.
METHODS: The CI/R rat model was established using middle cerebral artery occlusion/reperfusion (MCAO/R). Human neuroblastoma cell line SH-SY5Y was subjected to oxygen-glucose deprivation and reoxygenation (OGD/R). Ubiquitination assay, co-immunoprecipitation assay, RNA pull-down, and RNA immunoprecipitation were used to determine the interplay among TUG1, sirtuin 1 (SIRT1), and F-box and WD repeat domain-containing 7 (FBXW7).
RESULTS: The upregulation of the TUG1 level and downregulation of the mitophagy were observed in both MCAO/R-treated rats and OGD/R-treated cells. The administration of si-TUG1 (a siRNA directed against TUG1) potentiated mitophagy and suppressed neuronal apoptosis in OGD/R-treated cells. However, the neuroprotective effect of si-TUG1 was reversed by mitophagy inhibitor or SIRT1 knockdown in vitro. Functionally, TUG1 enhanced FBXW7-mediated SIRT1 ubiquitination by upregulating FBXW7 expression. The overexpression of FBXW7 abrogated the si-TUG1-reinforced mitophagy by decreasing SIRT1 expression, thus aggravating neuronal apoptosis in the OGD/R+si-TUG1-treated cells. In rats with MCAO/R, the interference of TUG1 clearly decreased neuronal apoptosis, lessened the infarct volume, and relieved the neurological deficits.
CONCLUSION: TUG1 knockdown promotes SIRT1-induced mitophagy by suppressing FBXW7-mediated SIRT1 degradation, thus relieving the neuronal apoptosis induced by CI/R injury. LncRNA TUG1 promotes neuronal apoptosis through inhibition of mitophagy. TUG1 decreased SIRT1 expression by promoting FBXW7-mediated SIRT1 ubiquitination. FBXW7/SIRT1 axis mediated the effect of TUG1 on OGD/R-induced neuronal apoptosis by regulating mitophagy.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cerebral ischemia/reperfusion; LncRNA TUG1; Mitophagy; Neuronal apoptosis; SIRT1

Year:  2022        PMID: 35348966     DOI: 10.1007/s10565-022-09700-w

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  4 in total

1.  Overexpression of TUG1 promotes neuronal death after cerebral infarction by regulating microRNA-9.

Authors:  Z-J Xiong; Q Zhang; D-X Wang; L Hu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-11       Impact factor: 3.507

2.  Salidroside attenuates hypoxia/reoxygenation-induced human brain vascular smooth muscle cell injury by activating the SIRT1/FOXO3α pathway.

Authors:  Lina Xu; Longbin Jia; Qingyun Wang; Jing Hou; Shifang Li; Junfang Teng
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

3.  Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.

Authors:  Hongzhu Yan; Chengmin Qiu; Weiwei Sun; Minmin Gu; Feng Xiao; Jue Zou; Li Zhang
Journal:  Oncol Rep       Date:  2018-02-07       Impact factor: 3.906

4.  MicroRNA‑217 inhibition relieves cerebral ischemia/reperfusion injury by targeting SIRT1.

Authors:  Gaofeng Rao; Wenfu Zhang; Shegeng Song
Journal:  Mol Med Rep       Date:  2019-05-31       Impact factor: 2.952

  4 in total
  2 in total

Review 1.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 2.  The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.

Authors:  Lu Xia; Jingyun Chen; Min Huang; Jie Mei; Min Lin
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.